Leisure sitting time associated with increased risk of cancer in women
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
For the study, researchers analyzed data from more than 146,000 men and women included in the American Cancer Society Cancer Prevention Study II Nutrition Cohort to compare leisure time sitting with cancer risk. Of the 77,462 women and 69,260 men, 12,236 women and 18,555 men were diagnosed with cancer between 1992 and 2009.
Results showed that leisure time sitting was associated with a 10% increased risk for developing cancer in women after adjusting for confounding factors, such as body mass index, physical activity, and other factors. Researchers found no association between sitting time and cancer risk in men.
The study demonstrated that sitting time was associated with an increased risk for developing invasive breast cancer, multiple myeloma, and ovarian cancer in women.
The authors note that further research is warranted to better understand the differences in associations of sitting time and cancer risk between men and women.
Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|